Dexvetidine 0.5 mg Solution is a Health Canada–registered veterinary drug (DIN 02483947) held by Modern Veterinary Therapeutics LLC, containing Dexmedetomidine Hydrochloride. Health Canada lists its status as Marketed (status date 13 Jun 2019). Nexara Health has matched 309 registrations of Dexmedetomidine Hydrochloride across 24 other regulated markets.
Health Canada registration
| DIN | 02483947 |
|---|---|
| Brand name | Dexvetidine |
| Active ingredient | Dexmedetomidine Hydrochloride |
| Strength | 0.5 mg |
| Dosage form | Solution |
| Route | Intramuscular ; Intravenous |
| Company | Modern Veterinary Therapeutics LLC |
| Status | Marketed — 13 Jun 2019 |
| Class | Veterinary |
| ATC | |
| AHFS | 84:80.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Dexmedetomidine Hydrochloride registered in other markets
309 registrations of the same molecule in 24 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bahrain | Dexmedetomidine Ever Pharma | Ever Valinject GmbH, Austria. | 100 MCG/ML | Concentrate For Solution For Infusion | POM | NHRA |
| Bahrain | Dexmedetomidine Ever Pharma | Ever Valinject GmbH, Austria. | 100 MCG/ML | Concentrate For Solution For Infusion | POM | NHRA |
| Bahrain | Dexmedetomidine Ever Pharma | Ever Valinject GmbH, Austria. | 100 MCG/ML | Concentrate For Solution For Infusion | POM | NHRA |
| Bahrain | Dexmedetomidine Kalceks | As Kalceks, Latvia. | 100 MCG/ML | Concentrate For Solution For Infusion | POM | NHRA |
| Bahrain | Nourax | Kuwait Saudi Pharmaceutical Industries Co. (Kspico), Kuwait. | 100 MCG/ML | Concentrate For Solution For Infusion | POM | NHRA |
| Bahrain | Sedalert | Tabuk Pharmaceutical Manufacturing Company, Ksa. | 200 MCG/2ML | Concentrate For Solution For Infusion | POM | NHRA |
| Bulgaria | Dexmedetomidine EVER Valinject | EVER Valinject GmbH | 100 micrograms/ ml concentrate for solution for infusion | концентрат за инфузионен разтвор | По лекарско предписание | BDA |
| Bulgaria | Dexmedetomidine Kalceks | AS Kalceks | 100 micrograms/ ml concentrate for solution for infusion | концентрат за инфузионен разтвор | По лекарско предписание | BDA |
| Croatia | Deksmedetomidin EVER Pharma | EVER Valinject GmbH | konc. za otop. za inf., boč. 4x10 ml (100 mcg/ml) | HZZO | ||
| Croatia | Deksmedetomidin EVER Pharma | EVER Valinject GmbH | konc. za otop. za inf., amp. 5x10 ml (100 mcg/ml) | HZZO | ||
| Croatia | Deksmedetomidin EVER Pharma | EVER Valinject GmbH | konc. za otop. za inf., amp. 5x4 ml (100 mcg/ml) | HZZO | ||
| Croatia | Deksmedetomidin EVER Pharma | EVER Valinject GmbH | konc. za otop. za inf., boč. 4x4 ml (100 mcg/ml) | HZZO | ||
| Croatia | Deksmedetomidin EVER Pharma | EVER Valinject GmbH | konc. za otop. za inf., amp. 25x2 ml (100 mcg/ml) | HZZO | ||
| Croatia | Deksmedetomidin Kabi | Fresenius Kabi d.o.o. | konc. za otop. za inf., boč. 10x2 ml (100 mcg/ml) | HZZO | ||
| Croatia | Deksmedetomidin Kalceks | AS Kalceks | konc. za otop. za inf., boč. 25x2 ml (100 mcg/ml) | HZZO | ||
| Croatia | Dexdor | Orion Corporation | konc. za otop. za inf., boč. 25x2 ml (100 mcg/ml) | HZZO | ||
| Czech Republic | Dexdor | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexdor | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexdor | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexdor | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexdor | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexmedetomidine B. Braun | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexmedetomidine Ever Pharma | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Dexmedetomidine Fmk | — | 100MCG/ML | Inf Cnc Sol | R | SUKL DLP |
| Denmark | Cepedex | CP-Pharma Handelsgesellschaft mbH | 0,5 mg/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Dexdomitor | Orion Corporation | 0.5 mg/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Dexdomitor | Orion Corporation | 0,1 mg/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Dexdor | Orion Corporation | 100 mikrogram/ml | koncentrat til infusionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Dexdormostart Vet. | Alfasan Nederland BV | 0,5 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Dexmedetomidin "Ever Pharma" | EVER Valinject GmbH | 100 mikrogram/ml | koncentrat til infusionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Dexmedetomidin "Ever Valinject" | EVER Valinject GmbH | 100 mikrogram/ml | koncentrat til infusionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Dexmedetomidin "Kalceks" | Kalceks AS | 100 mikrogram/ml | koncentrat til infusionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| European Union (EMA) | Cepedex | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Dexdomitor | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Dexdor | Orion Corporation | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Sedadex | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Sileo | — | Authorised | EMA centrally authorised | ||
| Finland | Cepedex | CP-Pharma Handelsgesellschaft mbH | 0.5 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Cepedex | CP-Pharma Handelsgesellschaft mbH | 0.1 mg/ml | injektioneste, liuos | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Dexdomitor | Orion Corporation | 0.1 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Dexdomitor | Orion Corporation | 0.5 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Dexdor | Orion Corporation | 100 mikrog/ml | infuusiokonsentraatti, liuosta varten | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Dexmedetomidine Accord | Accord Healthcare S.L.U. | 100 mikrog/ml | infuusiokonsentraatti, liuosta varten | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Dexmedetomidine Altan | Altan Pharma Limited | 100 mikrog/ml | infuusiokonsentraatti, liuosta varten | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Dexmedetomidine Altan Pharma | Altan Pharma Ltd | 4 mikrog/ml | infuusioneste, liuos | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Greece | DEXDOR C/S.SOL.IN 100MCG/ML BTx25AMPSx2ML | Orion Corporation Espoo, Φινλανδια | reimbursed | MoH deltio timwn | ||
| Greece | DEXDOR C/S.SOL.IN 100MCG/ML BTx4VIALSx10ML (κλεισμένο με γκρι ελαστικό πώμα από βρωμοβουτύλιο με επικάλυψη απο φθοριοπολυμερές omniflex plus) | Orion Corporation Espoo, Φινλανδια | reimbursed | MoH deltio timwn | ||
| Greece | Dexmedetomidine/Ariti C/S.sol.in 100mcg/mL Bt X 25 Amp X 2ml | Αρητη A.e. | reimbursed | MoH deltio timwn | ||
| Greece | Dexmedetomidine/Ariti C/S.sol.in 100mcg/mL Bt X 4 Vials X 10ml | Αρητη A.e. | reimbursed | MoH deltio timwn | ||
| Greece | Dexmedetomidine/Ariti Sol.inf 4mcg/mL Σακος Πολυπροπυλενιου: Bt X 4 Bags X 100ml | Αρητη A.e. | reimbursed | MoH deltio timwn | ||
| Greece | Dexmedetomidine/Baxter C/S.sol.in 100mcg/mL Bt X 5 Vials X 2ml | Baxter Holding B.v., The Netherlands | reimbursed | MoH deltio timwn | ||
| Greece | Dexmedetomidine/Ever Valinject C/S.sol.in 100mcg/mL 25 X 2 mL Amps | Ever Valinject GmbH, Austria | reimbursed | MoH deltio timwn | ||
| Greece | Dexmedetomidine/Ever Valinject C/S.sol.in 100mcg/mL 5 X 10 mL Amps | Ever Valinject GmbH, Austria | reimbursed | MoH deltio timwn | ||
| Iceland | Dexdomitor | Orion Corporation (I) | 0,5 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Dexdomitor | Icepharma - óskráð | 0,5 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Dexdor | Orion Corporation | 100 mcg/ml | irþ | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Sileo | Orion Corporation (I) | 0,1 mg/ml | munnh.hl | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Dexdor 100 micrograms/ml concentrate for solution for infusion | Orion Corporation | Concentrate for solution for infusion | Unknown | HPRA | |
| Ireland | Dexmedetomidine 100 microgram/ml concentrate for solution for infusion | Noridem Enterprises Limited | Concentrate for solution for infusion | Not marketed | HPRA | |
| Ireland | Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion | Baxter Holding B.V. | Concentrate for solution for infusion | Not marketed | HPRA | |
| Ireland | Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion | AS Kalceks | Concentrate for solution for infusion | Marketed | HPRA | |
| Ireland | Dexmedetomidine B. Braun 100 micrograms/ml concentrate for solution for infusion | B. Braun Melsungen AG | Concentrate for solution for infusion | Marketed | HPRA | |
| Ireland | Dexmedetomidine EVER Pharma 100 micrograms/ml concentrate for solution for infusion | EVER Valinject GmbH | Concentrate for solution for infusion | Marketed | HPRA | |
| Ireland | Dexmedetomidine Kabi 100 microgram/mL concentrate for solution for infusion | Fresenius Kabi Deutschland GmbH | Concentrate for solution for infusion | Not marketed | HPRA | |
| Jordan | Dexmedetomidine Ever Pharma | Ever Pharma Jena GmbH/Germany | 0.1182 MG/1 ML | Concentrate for solution for infusion | NEW APPLICATION | JFDA drug registrations |
| Jordan | Dexmedetomidine Ever Pharma | Ever Pharma Jena GmbH/Germany | 0.1182 MG/1 ML | Concentrate for solution for infusion | NEW APPLICATION | JFDA drug registrations |
| Jordan | Dexmedetomidine Ever Pharma | Ever Pharma Jena GmbH/Germany | 0.1182 MG/1 ML | Concentrate for solution for infusion | NEW APPLICATION | JFDA drug registrations |
| Malaysia | Dexdor 100 micrograms/ml concentrate for solution for infusion | Orion Pharma (My) Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malaysia | Dexmedetomidine EVER Pharma 200 µg/2ml Concentrate for solution for infusion | Dimensiss Healthcare Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Dexmedetomidine Fresenius 100 mcg/ml Concentrate for Solution for Infusion | Fresenius Kabi Malaysia Sdn. Bhd | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Dexmedetomidine Kabi 0.1mg/mL Concentrate for Infusion | Fresenius Kabi Malaysia Sdn. Bhd | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Emidex 100mcg/ml Concentrate for Solution for Infusion | Novugen Pharma Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | HYDEX (Dexmedetomidine Concentrate For Infusion 100mcg/ml, 2 ml vial) | Accord Healthcare Sdn.bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | ICUNES 100mcg/ml Concentrate for Solution for Infusion | Averroes Pharmaceuticals Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Precedex | Pfizer (Malaysia) Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Netherlands | Dexdor 100 micrograms/ml, concentraat voor oplossing voor infusie | Orion Corporation | Concentraat voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine Altan 4 microgram/ml oplossing voor infusie | Altan Pharma Ltd. | Oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine B. Braun 100 microgram/ml concentraat voor oplossing voor infusie | B. Braun Melsungen AG (Melsungen) | Concentraat voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine Baxter 100 microgram/ml concentraat voor oplossing voor infusie | Baxter B.V. | Concentraat voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine EVER Pharma 100 microgram/ml concentraat voor oplossing voor infusie | EVER-Valinject GmbH | Concentraat voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine hameln 4 microgram/ml oplossing voor infusie | hameln pharma gmbh | Oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine Hikma 100 microgram/ml concentraat voor oplossing voor infusie | Hikma Farmaceutica (Portugal), S.A. | Concentraat voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Dexmedetomidine Hikma 4 microgram/ml oplossing voor infusie | Hikma Farmaceutica (Portugal), S.A. | Oplossing voor infusie | Uitsluitend recept | EU national register | |
| Norway | Dexdor kons til inf oppl 100 mikrog/ml | Orion Corporation - Espoo | 5 x 2 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexdor kons til inf oppl 100 mikrog/ml | Orion Corporation - Espoo | 4 x 10 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexdor kons til inf oppl 100 mikrog/ml | Orion Corporation - Espoo | 4 x 4 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexdor kons til inf oppl 100 mikrog/ml | Orion Corporation - Espoo | 25 x 2 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexmedetomidine B. Braun kons til inf oppl 100 mikrog/ml | B. Braun Melsungen AG | 10 x 10 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexmedetomidine B. Braun kons til inf oppl 100 mikrog/ml | B. Braun Melsungen AG | 10 x 4 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexmedetomidine B. Braun kons til inf oppl 100 mikrog/ml | B. Braun Melsungen AG | 10 x 2 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Dexmedetomidine Ever Pharma kons til inf oppl 100 mikrog/ml | EVER Valinject GmbH | 4 x 10 | Konsentrat til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Poland | Dexdomitor | Orion Corporation | 0,5 mg/ml | Roztwór do wstrzykiwań | URPL RPL | |
| Poland | Dexdor | Orion Corporation | 100 mcg/ml | Koncentrat do sporządzania roztworu do infuzji | URPL RPL | |
| Poland | Dexmedetomidine Accord | Accord Healthcare S.L.U. | 100 mcg/ml | Koncentrat do sporządzania roztworu do infuzji | URPL RPL | |
| Poland | Dexmedetomidine Altan | Altan Pharma Ltd. | 100 mcg/ml | Koncentrat do sporządzania roztworu do infuzji | 2025-08-11 | URPL RPL |
| Poland | Dexmedetomidine Altan | Altan Pharma Ltd. | 4 mcg/ml | Roztwór do infuzji | 2025-08-11 | URPL RPL |
| Poland | Dexmedetomidine EVER Pharma | EVER Valinject GmbH | Koncentrat do sporządzania roztworu do infuzji | Bezterminowe | URPL RPL | |
| Poland | Dexmedetomidine Farmak | Farmak International Sp. z o.o. | 100 mcg/ml | Koncentrat do sporządzania roztworu do infuzji | 2030-12-30 | URPL RPL |
| Poland | Dexmedetomidine Kabi | Fresenius Kabi Polska Sp. z o.o. | 100 mikrogramów/ml | Koncentrat do sporządzania roztworu do infuzji | Bezterminowe | URPL RPL |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Romania | DEXMEDETOMIDINA EVER VALINJECT 100 micrograme/ml | — | 100micrograme/ml | Conc. Pt. Sol. Perf. | PR _x0002_ | ANMDMR nomenclator |
| Saudi Arabia | Demexa | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Dexdor | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Dexmedetomidine PSI | — | 4 | Inactive | SFDA | |
| Saudi Arabia | Dormidex | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Dormidex | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Dormidex | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Naplax | — | 4 | Inactive | SFDA | |
| Saudi Arabia | Naplax | — | 4 | Inactive | SFDA | |
| Serbia | Dexdor | Beohem - 3 D.o.o. | OBNOVA | ALIMS | ||
| Serbia | Dexmedetomidin MEDIKUNION | Medikunion Doo Beograd | REGISTRACIJA | ALIMS | ||
| Serbia | Dexmedetomidine Kabi | Fresenius Kabi D.o.o. Beograd | REGISTRACIJA | ALIMS | ||
| Serbia | Dexmedetomidine Kalceks | Grindeks Kalceks Rs D.o.o. Beograd | REGISTRACIJA | ALIMS | ||
| Serbia | Dexmedetomidine Pharmidea | Hemofarm Ad Vršac | REGISTRACIJA | ALIMS |
See every manufacturer of Dexmedetomidine Hydrochloride worldwide →
Regulator price references for Dexmedetomidine Hydrochloride
Published list or reimbursement prices for Dexmedetomidine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Bahrain | Sedalert | 0.2mg/2ml | 2ML | 6.11 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dexmedetomidine Kalceks | 0.1mg/1ml | 5 X 2ML | 30.16 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dexmedetomidine Ever Pharma | 0.1mg/1ml | 5 X 2ML | 48.56 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dexmedetomidine Ever Pharma | 0.1mg/1ml | 5 X 4ML | 97.12 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Nourax | 0.1mg/1ml | 25 X 2ML | 211.45 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dexmedetomidine Ever Pharma | 0.1mg/1ml | 5 X 10ML | 242.79 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Dexmedetomidine/Baxter C/S.sol.in 100mcg/mL Bt X 5 Vials X 2ml | 0.1mg/1ml | 47.72 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dexmedetomidine/Ariti Sol.inf 4mcg/mL Σακος Πολυπροπυλενιου: Bt X 4 Bags X 100ml | 0.004mg/1ml | 173.40 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dexmedetomidine/Ariti C/S.sol.in 100mcg/mL Bt X 4 Vials X 10ml | 0.1mg/1ml | 178.48 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dexmedetomidine/Ever Valinject C/S.sol.in 100mcg/mL 5 X 10 mL Amps | 0.1mg/1ml | 223.09 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dexmedetomidine/Ariti C/S.sol.in 100mcg/mL Bt X 25 Amp X 2ml | 0.1mg/1ml | 238.58 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dexmedetomidine/Ever Valinject C/S.sol.in 100mcg/mL 25 X 2 mL Amps | 0.1mg/1ml | 238.58 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DEXDOR C/S.SOL.IN 100MCG/ML BTx4VIALSx10ML (κλεισμένο με γκρι ελαστικό πώμα από βρωμοβουτύλιο με επικάλυψη απο φθοριοπολυμερές omniflex plus) | 0.1mg/1ml | 274.57 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DEXDOR C/S.SOL.IN 100MCG/ML BTx25AMPSx2ML | 0.1mg/1ml | 367.04 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Sileo | 0.1mg/1ml | spr | 4,352.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dexdomitor | 0.5mg/1ml | hgl | 7,115.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dexdomitor | 0.5mg/1ml | pakki | 7,294.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dexdor | 0.1mg/1ml | lykjur | 67,279.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Norway | Dexmedetomidine Ever Pharma | 2 ml | 1,151.90 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Kalceks | 2 ml | 1,151.90 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexdor | 2 ml | 1,296.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Kalceks | 4 ml | 1,929.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Ever Pharma | 4 ml | 1,929.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexdor | 4 ml | 2,052.00 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine B. Braun | 2 ml | 2,267.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine B. Braun | 4 ml | 4,769.70 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Ever Pharma | 10 ml | 4,817.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Kalceks | 10 ml | 4,817.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexdor | 10 ml | 5,075.70 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Kalceks | 2 ml | 6,220.00 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine Ever Pharma | 2 ml | 6,220.00 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexdor | 2 ml | 6,335.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Dexmedetomidine B. Braun | 10 ml | 11,989.40 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Saudi Arabia | Proxida | 71.20 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Naplax | 85.45 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Precedex 100 mcg -mL Iv. Vial | 0.1mg | 102.50 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dexmedetomidine PSI | 142.40 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dormidex | 302.05 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Soporidex | 395.70 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dormidex | 605.85 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Soporidex | 680.55 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Demexa | 712.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Naplax | 854.50 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dormidex | 1,514.60 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Soporidex | 1,592.30 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dexdor | 1,922.40 SAR | public | SFDA | 2026-09-01 | ||
| South Africa | Sedmedex 100 µg/ml | 0.1mg/1ml | 2 | 315.00 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Demodinex | 0.1mg/1ml | 2 | 322.00 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Precia | 0.1mg/1ml | 2 | 327.75 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sedalpha 100 µg/ml | 0.1mg/1ml | 2 | 327.75 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Dexisun | 0.1mg/1ml | 2 | 349.96 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | TOMEXA 200 μg/2 ml | 2ml | 2 | 364.66 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Eccladex | 0.1mg/1ml | 2 | 368.45 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Demetev | 0.1mg/1ml | 2 | 577.24 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Precedex | 0.1mg/1ml | 2 | 1,441.40 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Dexvetidine (DIN 02483947) marketed in Canada?
Yes. Health Canada lists DIN 02483947 as Marketed as of 13 Jun 2019.
Who holds the Canadian licence for this product?
Modern Veterinary Therapeutics LLC is the company of record in the Health Canada Drug Product Database.
Is Dexmedetomidine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 309 registrations in 24 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02483947, status date 2019-06-13; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02483947, status date 2019-06-13; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, SFDA.
Modern Veterinary Therapeutics LLC — company profileWho else makes Dexmedetomidine HydrochlorideAll Canadian Dexmedetomidine Hydrochloride products
Health Canada Drug Product Database (DPD), DIN 02483947, status date 2019-06-13; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.